Androgenetic Alopecia: An Update
July 2023
in “
JAAD International
”
androgenetic alopecia finasteride minoxidil dihydrotestosterone DHT low-level light therapy low-level laser therapy LLLT hair follicle transplantation Dutasteride phytomedicine platelet-rich plasma PRP mesenchymal stem cell-derived exosomes microneedling SRD5A2 clascoterone Janus kinase inhibitors stem cell therapies AGA Propecia Rogaine hair transplant stem cell exosomes JAK inhibitors stem cell treatments
Studysummary This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doi.org →